MindBio Therapeutics Advances in Psychedelic Research
LOS ANGELES- MindBio Therapeutics Corp. is on the brink of completing a pivotal Phase 2a clinical trial, marking a significant milestone in the study...
Optimi Health Corp Expands Psychedelic Substance Manufacturing Capabilities with Health Canada License Amendment
LOS ANGELES- Optimi Health Corp. a Health Canada licensed entity engaged in psychedelic substance research and formulation, has achieved a significant milestone in its...
MAPS Public Benefit Corporation Secures Over $100 Million for Groundbreaking PTSD Therapy
LOS ANGELES- MAPS Public Benefit Corporation a key player in mental healthcare innovation, has announced an oversubscribed Series A financing round, raising over $100...
Lykos Therapeutics Secures Over $100 Million in Series A Financing
LOS ANGELES- Lykos Therapeutics, previously known as MAPS Public Benefit Corporation, has achieved a significant milestone in its journey to revolutionize mental healthcare. The...
